CSS LLC’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

CSS LLC’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-27,800	Closed	-$1.77M	–	827
2019 Q4	$1.77M	Buy	+27,800	New	+$72.3K	0.1%	176

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

CSS LLC's BMY.RT Position: Q1 2021 in Review

CSS LLC sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 559,562 shares — an estimated $387K sold.

CSS LLC first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1.48M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

CSS LLC reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
CSS LLC sold 559,562 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $387K.
CSS LLC first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
CSS LLC's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.48M in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.